Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Models of psychedelic drug action: modulation of cortical-subcortical circuits
Manoj K. Doss, Maxwell B. Madden, Andrew Gaddis, et al.
Brain (2021) Vol. 145, Iss. 2, pp. 441-456
Open Access | Times Cited: 143

Showing 26-50 of 143 citing articles:

Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’
Rosalind McAlpine, George Blackburne, Sunjeev K. Kamboj
(2023)
Open Access | Times Cited: 20
With great power comes great vulnerability: an ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis
Daniel Villiger, Manuel Trachsel
Journal of Medical Ethics (2023) Vol. 49, Iss. 12, pp. 826-832
Open Access | Times Cited: 16
Neuroimaging in psychedelic drug development: past, present, and future
Matthew B. Wall, Rebecca Harding, Rayyan Zafar, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3573-3580
Open Access | Times Cited: 16
Deep CANALs: a deep learning approach to refining the canalization theory of psychopathology
Arthur Juliani, Adam Safron, Ryota Kanai
Neuroscience of Consciousness (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 6
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors
Klemens Egger, Helena D. Aicher, Paul Cumming, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 5
On the Varieties of Conscious Experiences: Altered Beliefs Under Psychedelics (ALBUS)
Adam Safron, Arthur Juliani, Nicco Reggente, et al.
(2020)
Closed Access | Times Cited: 41
5-HT2AR and NMDAR psychedelics induce similar hyper-synchronous states in the rat cognitive-limbic cortex-basal ganglia system
Ivani Brys, Sebastián A. Barrientos, Jon Ezra Ward, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 15
The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics
Marco Onofrj, Mirella Russo, Stefano Delli Pizzi, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Synthetic surprise as the foundation of the psychedelic experience
Roberto De Filippo, Dietmar Schmitz
Neuroscience & Biobehavioral Reviews (2024) Vol. 157, pp. 105538-105538
Open Access | Times Cited: 4
Psychedelics, OCD and related disorders: A systematic review
Marianna Graziosi, J. Rohde, Praachi Tiwari, et al.
Journal of Obsessive-Compulsive and Related Disorders (2024) Vol. 41, pp. 100873-100873
Closed Access | Times Cited: 4
Psychedelic-assisted therapy among sexual and gender minority communities
Brady D. Hanshaw, Mark Fusunyan, Chase T. M. Anderson, et al.
Nature Mental Health (2024) Vol. 2, Iss. 6, pp. 636-644
Closed Access | Times Cited: 4
Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper
Marianne Destoop, Pavel Mohr, Florence Butlen-Ducuing, et al.
European Psychiatry (2025) Vol. 68, Iss. 1
Open Access
Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights
I. Craig Henderson, Ronnie Elsaadany, Gabriel Chan, et al.
Current Pain and Headache Reports (2025) Vol. 29, Iss. 1
Closed Access
Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review
Joshua Liebnau, Felix Betzler, André Kerber
Journal of Psychopharmacology (2025)
Open Access
Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis
Parastoo Yousefi, Morten Peter Lietz, Fiachra O'Higgins, et al.
Psychopharmacology (2025)
Open Access
On the varieties of conscious experiences: Altered Beliefs Under Psychedelics (ALBUS)
Adam Safron, Arthur Juliani, Nicco Reggente, et al.
Neuroscience of Consciousness (2025) Vol. 2025, Iss. 1
Open Access
Editorial for psychedelic and psychedelic and psychedelic-like states
David B. Yaden
International Review of Psychiatry (2025), pp. 1-6
Closed Access
Differential large-scale network functional connectivity in cocaine-use disorder associates with drug-use outcomes
Paul S. Regier, Nathan Hager, Michael J. Gawrysiak, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives
Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, et al.
Advanced Science (2025)
Open Access
Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortex
Brian H. Silverstein, Nicholas Kolbman, Amanda Nelson, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis
Haley Maria Dourron, Camilla K. Strauss, Peter S. Hendricks
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 984-1029
Open Access | Times Cited: 21
A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
Blerida Banushi, Vince Polito
Biology (2023) Vol. 12, Iss. 11, pp. 1380-1380
Open Access | Times Cited: 11
Psychedelics in the treatment of unipolar and bipolar depression
Oliver G. Bosch, Simon Halm, Erich Seifritz
International Journal of Bipolar Disorders (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 18
Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity
Andrew Gaddis, Daniel E. Lidstone, Mary Beth Nebel, et al.
NeuroImage (2022) Vol. 260, pp. 119434-119434
Open Access | Times Cited: 17
Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience
S. Parker Singleton, Christopher Timmermann, Andrea I. Luppi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10

Scroll to top